FI753543A - - Google Patents

Info

Publication number
FI753543A
FI753543A FI753543A FI753543A FI753543A FI 753543 A FI753543 A FI 753543A FI 753543 A FI753543 A FI 753543A FI 753543 A FI753543 A FI 753543A FI 753543 A FI753543 A FI 753543A
Authority
FI
Finland
Application number
FI753543A
Other languages
Finnish (fi)
Other versions
FI62089B (fi
FI62089C (fi
Inventor
Wilhelm Konz
Richard Reichl
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of FI753543A publication Critical patent/FI753543A/fi
Publication of FI62089B publication Critical patent/FI62089B/fi
Application granted granted Critical
Publication of FI62089C publication Critical patent/FI62089C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI753543A 1974-12-21 1975-12-16 Foerfarande foer framstaellning av pao det perifera blodomloppet verkande 7-(n-(3-fenoxi-2-hydroxipropyl)-n-amino)-1,3-dialkyl-xantinderivat FI62089C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19742460929 DE2460929A1 (de) 1974-12-21 1974-12-21 Neue xanthinderivate, verfahren zu ihrer herstellung und ihre anwendung
DE2460929 1974-12-21

Publications (3)

Publication Number Publication Date
FI753543A true FI753543A (xx) 1976-06-22
FI62089B FI62089B (fi) 1982-07-30
FI62089C FI62089C (fi) 1982-11-10

Family

ID=5934312

Family Applications (1)

Application Number Title Priority Date Filing Date
FI753543A FI62089C (fi) 1974-12-21 1975-12-16 Foerfarande foer framstaellning av pao det perifera blodomloppet verkande 7-(n-(3-fenoxi-2-hydroxipropyl)-n-amino)-1,3-dialkyl-xantinderivat

Country Status (31)

Country Link
US (1) US3998953A (xx)
JP (1) JPS5188995A (xx)
AT (1) AT341540B (xx)
AU (1) AU501889B2 (xx)
BE (1) BE836898A (xx)
BG (1) BG25518A3 (xx)
CA (1) CA1036159A (xx)
CH (1) CH628346A5 (xx)
CS (1) CS191289B2 (xx)
DD (1) DD124984A5 (xx)
DE (1) DE2460929A1 (xx)
DK (1) DK137677C (xx)
ES (2) ES443738A1 (xx)
FI (1) FI62089C (xx)
FR (1) FR2294706A1 (xx)
GB (1) GB1517710A (xx)
GR (1) GR59204B (xx)
HU (1) HU174673B (xx)
IE (1) IE43208B1 (xx)
IL (1) IL48697A (xx)
LU (1) LU73972A1 (xx)
NL (1) NL7514837A (xx)
NO (1) NO144928C (xx)
NZ (1) NZ179599A (xx)
PH (1) PH11810A (xx)
PL (1) PL99165B1 (xx)
RO (1) RO68381A (xx)
SE (1) SE420493B (xx)
SU (1) SU603340A3 (xx)
YU (1) YU39004B (xx)
ZA (1) ZA757865B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337254A (en) * 1977-08-23 1982-06-29 Burroughs Wellcome Co. Pharmaceutical compositions
DE3113880A1 (de) * 1981-04-07 1982-10-21 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von coffein
IT1174773B (it) * 1983-07-29 1987-07-01 Medosan Ind Biochimi Attivita' antiaggregante piastrinica e broncolitica della 7-(1-metil-5-p-metilbenzoilpirrol-2-acetamidoetil)teofillina
US5736528A (en) * 1993-10-28 1998-04-07 University Of Florida Research Foundation, Inc. N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists
US5446046A (en) * 1993-10-28 1995-08-29 University Of Florida Research Foundation A1 adenosine receptor agonists and antagonists as diuretics
US5620676A (en) * 1994-03-08 1997-04-15 The United States Of America As Represented By The Department Of Health And Human Services Biologically active ATP analogs
US5789416B1 (en) * 1996-08-27 1999-10-05 Cv Therapeutics Inc N6 mono heterocyclic substituted adenosine derivatives
WO1999031101A1 (en) * 1997-12-17 1999-06-24 University Of South Florida Adenosine receptor antagonists with improved bioactivity
US6576619B2 (en) 1999-05-24 2003-06-10 Cv Therapeutics, Inc. Orally active A1 adenosine receptor agonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1230663A (xx) * 1968-12-10 1971-05-05
US3728346A (en) * 1971-07-16 1973-04-17 Degussa Hydroxyphenylhydroxyalkylaminoalkyltheophyllines
JPS5132638B2 (xx) * 1972-07-13 1976-09-14

Also Published As

Publication number Publication date
CH628346A5 (de) 1982-02-26
CS191289B2 (en) 1979-06-29
BE836898A (fr) 1976-06-21
SE7514477L (sv) 1976-06-22
DK137677B (da) 1978-04-17
DK137677C (da) 1978-09-25
FI62089B (fi) 1982-07-30
ATA904575A (de) 1977-06-15
YU39004B (en) 1983-12-31
BG25518A3 (en) 1978-10-10
DE2460929C2 (xx) 1987-12-17
NL7514837A (nl) 1976-06-23
HU174673B (hu) 1980-03-28
FI62089C (fi) 1982-11-10
CA1036159A (en) 1978-08-08
AT341540B (de) 1978-02-10
IL48697A (en) 1979-07-25
DE2460929A1 (de) 1976-06-24
ES451457A1 (es) 1977-10-01
RO68381A (ro) 1982-02-26
US3998953A (en) 1976-12-21
NO144928B (no) 1981-08-31
GR59204B (en) 1977-11-26
FR2294706B1 (xx) 1978-12-01
ES443738A1 (es) 1977-04-16
AU8754775A (en) 1977-06-23
IE43208L (en) 1976-06-21
NZ179599A (en) 1978-03-06
IE43208B1 (en) 1981-01-14
DD124984A5 (xx) 1977-03-23
PL99165B1 (pl) 1978-06-30
NO144928C (no) 1981-12-09
ZA757865B (en) 1977-08-31
JPS5188995A (xx) 1976-08-04
FR2294706A1 (fr) 1976-07-16
NO754317L (xx) 1976-06-22
DK571875A (da) 1976-06-22
GB1517710A (en) 1978-07-12
SE420493B (sv) 1981-10-12
IL48697A0 (en) 1976-02-29
PH11810A (en) 1978-07-10
SU603340A3 (ru) 1978-04-15
AU501889B2 (en) 1979-07-05
LU73972A1 (xx) 1977-02-15
YU323475A (en) 1982-08-31

Similar Documents

Publication Publication Date Title
FR2294706B1 (xx)
JPS50108135U (xx)
FR2277089B1 (xx)
JPS50102949U (xx)
JPS50106014U (xx)
CH567925A5 (xx)
BG26544A3 (xx)
CH577399A5 (xx)
CH577283A5 (xx)
CH577150A5 (xx)
CH576925A5 (xx)
CH576645A5 (xx)
CH576020A5 (xx)
CH575116A5 (xx)
CH574074A5 (xx)
CH573545A5 (xx)
CH570727A5 (xx)
CH569931A5 (xx)
CH569303A5 (xx)
CH568564A5 (xx)
CH577702B5 (xx)
CH565470A5 (xx)
CH563212A5 (xx)
CH562379A5 (xx)
CH329975A4 (xx)

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: C.H. BOEHRINGER SOHN